- Home
- BRZE vs PTGX Comparison
BRZE vs PTGX Comparison
Compare BRZE & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRZE
- PTGX
- Stock Information
- Founded
- BRZE 2011
- PTGX 2006
- Country
- BRZE United States
- PTGX United States
- Employees
- BRZE N/A
- PTGX N/A
- Industry
- BRZE Computer Software: Prepackaged Software
- PTGX Biotechnology: Pharmaceutical Preparations
- Sector
- BRZE Technology
- PTGX Health Care
- Exchange
- BRZE Nasdaq
- PTGX Nasdaq
- Market Cap
- BRZE 3.1B
- PTGX 5.0B
- IPO Year
- BRZE 2021
- PTGX 2016
- Fundamental
- Price
- BRZE $28.36
- PTGX $83.89
- Analyst Decision
- BRZE Strong Buy
- PTGX Strong Buy
- Analyst Count
- BRZE 20
- PTGX 9
- Target Price
- BRZE $44.65
- PTGX $86.22
- AVG Volume (30 Days)
- BRZE 1.4M
- PTGX 998.7K
- Earning Date
- BRZE 12-08-2025
- PTGX 11-06-2025
- Dividend Yield
- BRZE N/A
- PTGX N/A
- EPS Growth
- BRZE N/A
- PTGX N/A
- EPS
- BRZE N/A
- PTGX 0.72
- Revenue
- BRZE $654,622,000.00
- PTGX $209,217,000.00
- Revenue This Year
- BRZE $23.36
- PTGX N/A
- Revenue Next Year
- BRZE $17.31
- PTGX $140.23
- P/E Ratio
- BRZE N/A
- PTGX $115.56
- Revenue Growth
- BRZE 22.16
- PTGX N/A
- 52 Week Low
- BRZE $23.91
- PTGX $33.31
- 52 Week High
- BRZE $48.33
- PTGX $93.25
- Technical
- Relative Strength Index (RSI)
- BRZE 52.61
- PTGX 68.79
- Support Level
- BRZE $26.23
- PTGX $76.70
- Resistance Level
- BRZE $28.64
- PTGX $80.43
- Average True Range (ATR)
- BRZE 1.16
- PTGX 2.82
- MACD
- BRZE 0.12
- PTGX 0.11
- Stochastic Oscillator
- BRZE 77.19
- PTGX 98.00
About BRZE Braze Inc.
Braze Inc is a customer engagement platform that powers customer-centric interactions between consumers and brands. The company provides solutions for Retail & E-commerce, Media & Entertainment, Financial Services, and Travel & Hospitality related industries. The company offers a single, vertically integrated platform that encompasses the various functionalities, or layers, required for modern customer engagement: data ingestion, classification, orchestration, personalization, and action, all of which is supported by Sage AI by Braze, its AI engine designed to power AI functionality across all layers of this stack. It generates majority of its revenue from the United States.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.